ScholarWorks@Korea University College of Medicine: Kang, Dong Oh

Detailed Information

Kang, Dong Oh (강동오)

Guro Hospital (Department of Cardiology, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

percutaneous coronary intervention:4||coronary artery disease:4||drugeluting stent:4||Diabetes mellitus:3||Myocardial infarction:3||Acute myocardial infarction:2||sarcopenia:2||computed tomography:2||skeletal muscle index:2||Statins:2||nonSTelevation myocardial infarction:2||nonSTsegment elevation myocardial infarction:2||cardiorespiratory fitness:2||Coronary artery spasm:2||outcomes:2||prehospital delay:2||Percutaneous coronary intervention:2||Hypertension:2||Calcium channel blocker:1||Cardiopulmonary coupling analysis:1||Cardiorespiratory Fitness:1||Cardiorespiratory fitness:1||Cardiovascular Disease:1||Cardiovascular outcome:1||Chest pain:1||Chronic kidney disease:1||Cilostazol:1||Clinical outcomes:1||Coronary artery disease:1||DES:1||Drug eluting stents:1||Drugeluting stent:1||Efferocytosis:1||Exercise Capacity:1||Foam cells:1||Haematopoietic activity:1||Heart failure:1||Hyperuricemia:1||Insignificant stenosis:1||L1 SMI:1||MACE:1||MINOCA:1||Macrophage targetable phototheranostic agent:1||Major adverse cardiac event:1||Major adverse cardiac events:1||Metabolic equivalent:1||Mortality:1||Multiple pulmonary nodules:1||Neoplasm metastasis:1||Newonset diabetes mellitus:1||Nomogram:1||NonST Elevated Myocardial Infarction:1||OCTNIRF:1||Oxygen consumption:1||PPAR gamma:1||Pathophysiology:1||Percutaneous Coronary Intervention:1||Photodynamic therapy:1||Prognosis:1||Rosuvastatin:1||STelevation myocardial infarction:1||Sarcoma, endometrial stromal:1||Sex Factors:1||Sleep apnea:1||Sleep disorders:1||Sleep quality:1||Type 2 diabetes:1||Uric acid:1||Validation study:1||Zotarolimus:1||antithrombotic therapy:1||arterial stiffness:1||atherosclerosis:1||atrial fibrillation:1||cardiovascular disease:1||cardiovascular events:1||celecoxib:1||cerebral infarction:1||chronic total occlusion:1||coronary heart disease:1||diabetes:1||diabetes mellitus:1||drug delivery:1||dual antiplatelet therapy:1||elderly:1||electrocardiography:1||ethnic groups:1||exercise capacity:1||fluorescence lifetime imaging:1||followup:1||global health:1||hand grip strength:1||handgrip:1||healthy volunteers:1||highrisk plaque:1||inflammation:1||lipid:1||long lesion: percutaneous coronary intervention:1||machine learning:1||meloxicam:1||myocardial infarction:1||nonSTsegmentelevation myocardial infarction:1||nonsteroidal antiinflammatory drugs:1||odds ratio:1||optical coherence tomography:1||prognosis:1||recovery of function:1||reperfusion:1||safety:1||sex discrepancies:1||sleep:1||stroke:1||targeted theranostics:1||triple antithrombotic therapy:1||validation studies:1||warfarin:1||(V)over doto(2max):1||zotarolimus:1||18FFDGPET/CT:1||24hour Holter study:1||6minute walk test:1||Ach: acetylcholine:1||Amygdalar activity:1||Angiotensin II type 1 receptor blocker:1||Angiotensin converting enzyme inhibitor:1||Antiplatelet therapy:1||Arterial inflammation:1||Asian:1||Atherosclerosis:1||Atorvastatin:1||Atrial fibrillation:1||Autophagy:1||Blood glucose:1||Creactive protein:1||CAS:1||

STATISTICS: Total View :12,660,958; Today View :7,237

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE